Lefitolimod

Tax included
Lefitolimod (MGN 1703) is a DNA-based TLR9 agonist and an immune surveillance reactivator. Lefitolimod induces HIV-specific immune responses and can be used for the research of cancer and HIV-1.
HY-P2375

Data sheet

Size
Multiple sizes
Reactivity
Toll-like Receptor (TLR); HIV
Application
COVID-19-anti-virus
CAS
1548439-51-5